Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
01 2020
Historique:
received: 26 02 2019
accepted: 08 11 2019
pubmed: 20 12 2019
medline: 21 4 2020
entrez: 20 12 2019
Statut: ppublish

Résumé

Chronic inflammation is accompanied by recurring cycles of tissue destruction and repair and is associated with an increased risk of cancer

Identifiants

pubmed: 31853061
doi: 10.1038/s41586-019-1856-1
pii: 10.1038/s41586-019-1856-1
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
NFKBIZ protein, human 0
Nfkbiz protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

260-265

Commentaires et corrections

Type : CommentIn

Références

Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).
doi: 10.1016/j.cell.2010.01.025
Hunter, P. The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO Rep. 13, 968–970 (2012).
doi: 10.1038/embor.2012.142
Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871–882 (2010).
doi: 10.1016/j.cell.2010.02.029
Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488–2498 (2014).
doi: 10.1056/NEJMoa1408617
Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).
pubmed: 25999502 pmcid: 4471149
Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312–317 (2019).
doi: 10.1038/s41586-018-0811-x
Burisch, J., Jess, T., Martinato, M. & Lakatos, P. L. The burden of inflammatory bowel disease in Europe. J. Crohns Colitis 7, 322–337 (2013).
doi: 10.1016/j.crohns.2013.01.010
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L. & Colombel, J. F. Ulcerative colitis. Lancet 389, 1756–1770 (2017).
doi: 10.1016/S0140-6736(16)32126-2
Eaden, J. A., Abrams, K. R. & Mayberry, J. F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48, 526–535 (2001).
doi: 10.1136/gut.48.4.526
Kang, H. & Shibata, D. Direct measurements of human colon crypt stem cell niche genetic fidelity: the role of chance in non-Darwinian mutation selection. Front. Oncol. 3, 264 (2013).
doi: 10.3389/fonc.2013.00264
Choi, C. R., Bakir, I. A., Hart, A. L. & Graham, T. A. Clonal evolution of colorectal cancer in IBD. Nat. Rev. Gastroenterol. Hepatol. 14, 218–229 (2017).
doi: 10.1038/nrgastro.2017.1
Eto, A., Muta, T., Yamazaki, S. & Takeshige, K. Essential roles for NF-κB and a Toll/IL-1 receptor domain-specific signal(s) in the induction of IκB-ζ. Biochem. Biophys. Res. Commun. 301, 495–501 (2003).
doi: 10.1016/S0006-291X(02)03082-6
Yamamoto, M. et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ. Nature 430, 218–222 (2004).
doi: 10.1038/nature02738
Bruno, M. E. C., Frantz, A. L., Rogier, E. W., Johansen, F. E. & Kaetzel, C. S. Regulation of the polymeric immunoglobulin receptor by the classical and alternative NF-κB pathways in intestinal epithelial cells. Mucosal Immunol. 4, 468–478 (2011).
doi: 10.1038/mi.2011.8
Cao, A. T., Yao, S., Gong, B., Elson, C. O. & Cong, Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J. Immunol. 189, 4666–4673 (2012).
doi: 10.4049/jimmunol.1200955
Bruno, M. E. et al. Correlation of biomarker expression in colonic mucosa with disease phenotype in Crohn’s disease and ulcerative colitis. Dig. Dis. Sci. 60, 2976–2984 (2015).
doi: 10.1007/s10620-015-3700-2
Nakatsuka, Y. et al. Pulmonary Regnase-1 orchestrates the interplay of epithelium and adaptive immune systems to protect against pneumonia. Mucosal Immunol. 11, 1203–1218 (2018).
doi: 10.1038/s41385-018-0024-5
Mino, T. et al. Regnase-1 and Roquin regulate a common element in inflammatory mRNAs by spatiotemporally distinct mechanisms. Cell 161, 1058–1073 (2015).
doi: 10.1016/j.cell.2015.04.029
Iwasaki, H. et al. The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat. Immunol. 12, 1167–1175 (2011).
doi: 10.1038/ni.2137
Reznik, B., Clement, S. L. & Lykke-Andersen, J. hnRNP F complexes with tristetraprolin and stimulates ARE-mRNA decay. PLoS One 9, e100992 (2014).
doi: 10.1371/journal.pone.0100992
Ramirez-Carrozzi, V. et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat. Immunol. 12, 1159–1166 (2011).
doi: 10.1038/ni.2156
Robles, A. I. et al. Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology 150, 931–943 (2016).
doi: 10.1053/j.gastro.2015.12.036
Fujita, M. et al. Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling. Oncotarget 9, 969–981 (2018).
doi: 10.18632/oncotarget.22867
Din, S. et al. Mutational analysis identifies therapeutic biomarkers in inflammatory bowel disease-associated colorectal cancers. Clin. Cancer Res. https://doi.org/10.1158/1078-0432.CCR-17-3713 (2018).
Baker, A. M. et al. Evolutionary history of human colitis-associated colorectal cancer. Gut 68, 985–995 (2019).
doi: 10.1136/gutjnl-2018-316191
Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).
doi: 10.1038/nature11582
Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).
doi: 10.1038/ng.3359
Riddell, R. H. et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol. 14, 931–968 (1983).
doi: 10.1016/S0046-8177(83)80175-0
Yoshida, K. et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64–69 (2011).
doi: 10.1038/nature10496
Shiraishi, Y. et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data. Nucleic Acids Res. 41, e89 (2013).
doi: 10.1093/nar/gkt126
Okuma, A. et al. Enhanced apoptosis by disruption of the STAT3-IκB-ζ signaling pathway in epithelial cells induces Sjögren’s syndrome-like autoimmune disease. Immunity 38, 450–460 (2013).
doi: 10.1016/j.immuni.2012.11.016
el Marjou, F. et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39, 186–193 (2004).
doi: 10.1002/gene.20042
Miyoshi, H. & Stappenbeck, T. S. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat. Protoc. 8, 2471–2482 (2013).
doi: 10.1038/nprot.2013.153
Katakura, K. et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115, 695–702 (2005).
doi: 10.1172/JCI22996
Chen, K. et al. IL-17 Receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against K. pneumoniae. Cell Host Microbe 20, 596–605 (2016).
doi: 10.1016/j.chom.2016.10.003
Johansen, C. et al. IκBζ is a key driver in the development of psoriasis. Proc. Natl Acad. Sci. USA 112, E5825–E5833 (2015).
doi: 10.1073/pnas.1509971112
Müller, A. et al. IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes. Proc. Natl Acad. Sci. USA 115, 10088–10093 (2018).
doi: 10.1073/pnas.1801377115
Hildebrand, D. G. et al. IκBζ is a transcriptional key regulator of CCL2/MCP-1. J. Immunol. 190, 4812–4820 (2013).
doi: 10.4049/jimmunol.1300089
Goto, N. et al. Distinct roles of Hes1 in normal stem cells and tumor stem-like cells of the intestine. Cancer Res. 77, 3442–3454 (2017).
doi: 10.1158/0008-5472.CAN-16-3192
Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260–264 (2016).
doi: 10.1038/nature19768

Auteurs

Nobuyuki Kakiuchi (N)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.

Kenichi Yoshida (K)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.

Motoi Uchino (M)

Department of Inflammatory Bowel Disease, Division of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.

Takako Kihara (T)

Department of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Japan.

Kotaro Akaki (K)

Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Yoshikage Inoue (Y)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
Department of Surgery, Kyoto University, Kyoto, Japan.

Kenji Kawada (K)

Department of Surgery, Kyoto University, Kyoto, Japan.

Satoshi Nagayama (S)

Gastroenterological Center, Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Akira Yokoyama (A)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Shuji Yamamoto (S)

Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.

Minoru Matsuura (M)

Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.

Takahiro Horimatsu (T)

Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Tomonori Hirano (T)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.

Norihiro Goto (N)

Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.

Yasuhide Takeuchi (Y)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan.

Yotaro Ochi (Y)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Yusuke Shiozawa (Y)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.

Yasunori Kogure (Y)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Division of Molecular Oncology, National Cancer Centre Research Institute, Tokyo, Japan.

Yosaku Watatani (Y)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Yoichi Fujii (Y)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Soo Ki Kim (SK)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.

Ayana Kon (A)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Keisuke Kataoka (K)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Division of Molecular Oncology, National Cancer Centre Research Institute, Tokyo, Japan.

Tetsuichi Yoshizato (T)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.

Masahiro M Nakagawa (MM)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Akinori Yoda (A)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Yasuhito Nanya (Y)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Hideki Makishima (H)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Yuichi Shiraishi (Y)

Laboratory of DNA Information Analysis, Human Genome Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Kenichi Chiba (K)

Laboratory of DNA Information Analysis, Human Genome Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Hiroko Tanaka (H)

Laboratory of Sequence Analysis, Human Genome Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Masashi Sanada (M)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
Department of Advanced Diagnosis, Clinical Research Centre, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

Eiji Sugihara (E)

Research and Development Centre for Precision Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Taka-Aki Sato (TA)

Research and Development Centre for Precision Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Takashi Maruyama (T)

Department of Immunology, Akita University Graduate School of Medicine, Akita, Japan.

Hiroyuki Miyoshi (H)

Division of Experimental Therapeutics, Kyoto University, Kyoto, Japan.

Makoto Mark Taketo (MM)

Division of Experimental Therapeutics, Kyoto University, Kyoto, Japan.

Jun Oishi (J)

DSP Cancer Institute, Sumitomo Dainippon Pharma, Osaka, Japan.

Ryosaku Inagaki (R)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan.
DSP Cancer Institute, Sumitomo Dainippon Pharma, Osaka, Japan.

Yutaka Ueda (Y)

DSP Cancer Institute, Sumitomo Dainippon Pharma, Osaka, Japan.

Shinya Okamoto (S)

Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Hideaki Okajima (H)

Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Paediatric Surgery, Kanazawa Medical University, Ishikawa, Japan.

Yoshiharu Sakai (Y)

Department of Surgery, Kyoto University, Kyoto, Japan.

Takaki Sakurai (T)

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

Hironori Haga (H)

Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan.

Seiichi Hirota (S)

Department of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Japan.

Hiroki Ikeuchi (H)

Department of Inflammatory Bowel Disease, Division of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.

Hiroshi Nakase (H)

Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Hiroyuki Marusawa (H)

Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.

Tsutomu Chiba (T)

Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
Kansai Electric Power Hospital, Osaka, Japan.

Osamu Takeuchi (O)

Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Satoru Miyano (S)

Laboratory of DNA Information Analysis, Human Genome Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Laboratory of Sequence Analysis, Human Genome Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Hiroshi Seno (H)

Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumour Biology, Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.
Department of Medicine, Centre for Haematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden. sogawa-tky@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH